ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004

Reversing Policy On Cancer Control Research, New Center Guidelines Top Accomplishments, Terry Believes

August 21, 1981

In Brief: Wyngaarden Suspends NIH Funds for Pennsylvania Head Injury Center Over Animal Care Problems

July 26, 1985

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

In Brief: Mauer New AACI President, Steckel Named President-Elect; Prevention Conference Set

January 25, 1980

ASCO Survey Finds Docs’ Quality Time With Patients Down, Due To Paperwork.

June 22, 2001